{"paper_id": "2a63d08ca1e3973347b4729393d7800b03829e17", "metadata": {"title": "Supporting Information Comprehensive Insights into the Catalytic Mechanism of Middle East Respiratory Syndrome 3C-Like Protease and Severe Acute Respiratory Syndrome 3C-Like Protease", "authors": [{"first": "Hao", "middle": [], "last": "Wang", "suffix": "", "affiliation": {"laboratory": "State Key Laboratory of Medicinal Chemical Biology", "institution": "Nankai University", "location": {"addrLine": "No.38 Tongyan Road, Haihe Education Park", "postCode": "300350", "settlement": "Tianjin", "country": "People's Republic of China"}}, "email": ""}, {"first": "Shuai", "middle": [], "last": "He", "suffix": "", "affiliation": {"laboratory": "State Key Laboratory of Medicinal Chemical Biology", "institution": "Nankai University", "location": {"addrLine": "No.38 Tongyan Road, Haihe Education Park", "postCode": "300350", "settlement": "Tianjin", "country": "People's Republic of China"}}, "email": ""}, {"first": "Weilong", "middle": [], "last": "Deng", "suffix": "", "affiliation": {"laboratory": "State Key Laboratory of Medicinal Chemical Biology", "institution": "Nankai University", "location": {"addrLine": "No.38 Tongyan Road, Haihe Education Park", "postCode": "300350", "settlement": "Tianjin", "country": "People's Republic of China"}}, "email": ""}, {"first": "Ying", "middle": [], "last": "Zhang", "suffix": "", "affiliation": {"laboratory": "Laboratory of Structural Biological & Ministry of Education and Laboratory of Protein Science", "institution": "Tsinghua University", "location": {"postCode": "100084", "settlement": "Beijing", "country": "People's Republic of China"}}, "email": ""}, {"first": "Guobang", "middle": [], "last": "Li", "suffix": "", "affiliation": {"laboratory": "State Key Laboratory of Medicinal Chemical Biology", "institution": "Nankai University", "location": {"addrLine": "No.38 Tongyan Road, Haihe Education Park", "postCode": "300350", "settlement": "Tianjin", "country": "People's Republic of China"}}, "email": ""}, {"first": "Jixue", "middle": [], "last": "Sun", "suffix": "", "affiliation": {"laboratory": "State Key Laboratory of Medicinal Chemical Biology", "institution": "Nankai University", "location": {"addrLine": "No.38 Tongyan Road, Haihe Education Park", "postCode": "300350", "settlement": "Tianjin", "country": "People's Republic of China"}}, "email": ""}, {"first": "Wei", "middle": [], "last": "Zhao", "suffix": "", "affiliation": {"laboratory": "State Key Laboratory of Medicinal Chemical Biology", "institution": "Nankai University", "location": {"addrLine": "No.38 Tongyan Road, Haihe Education Park", "postCode": "300350", "settlement": "Tianjin", "country": "People's Republic of China"}}, "email": ""}, {"first": "Yu", "middle": [], "last": "Guo", "suffix": "", "affiliation": {"laboratory": "State Key Laboratory of Medicinal Chemical Biology", "institution": "Nankai University", "location": {"addrLine": "No.38 Tongyan Road, Haihe Education Park", "postCode": "300350", "settlement": "Tianjin", "country": "People's Republic of China"}}, "email": ""}, {"first": "Zheng", "middle": [], "last": "Yin", "suffix": "", "affiliation": {"laboratory": "State Key Laboratory of Medicinal Chemical Biology", "institution": "Nankai University", "location": {"addrLine": "No.38 Tongyan Road, Haihe Education Park", "postCode": "300350", "settlement": "Tianjin", "country": "People's Republic of China"}}, "email": ""}, {"first": "Dongmei", "middle": [], "last": "Li", "suffix": "", "affiliation": {"laboratory": "State Key Laboratory of Medicinal Chemical Biology", "institution": "Nankai University", "location": {"addrLine": "No.38 Tongyan Road, Haihe Education Park", "postCode": "300350", "settlement": "Tianjin", "country": "People's Republic of China"}}, "email": ""}, {"first": "Luqing", "middle": [], "last": "Shang", "suffix": "", "affiliation": {"laboratory": "State Key Laboratory of Medicinal Chemical Biology", "institution": "Nankai University", "location": {"addrLine": "No.38 Tongyan Road, Haihe Education Park", "postCode": "300350", "settlement": "Tianjin", "country": "People's Republic of China"}}, "email": "shanglq@nankai.edu.cn"}]}, "abstract": [], "body_text": [{"text": "3CL Pro and SARS-CoV 3CL Pro , respectively. Figure S19 . Molecular catalytic mechanism of EV71 3C Pro . Figure S20 . Sequence alignment of six common coronavirus 3CL Pro (MERS-CoV 3CL Pro , SARS-CoV 3CL Pro , HCoV-HKU1 3CL Pro , BCoV-HKU4 3CL Pro , HCoV-229E 3CL Pro , HCoV-NL63 3CL Pro ). High conserved residues were shown in red background, \u03b1-helices in helix, \u03b2-sheets in arrow and turn in T symbol. Supporting tables Table S1 . The designed primers for construction of plasmid.", "cite_spans": [], "ref_spans": [{"start": 45, "end": 55, "text": "Figure S19", "ref_id": null}, {"start": 105, "end": 115, "text": "Figure S20", "ref_id": "FIGREF22"}, {"start": 423, "end": 431, "text": "Table S1", "ref_id": null}], "section": "5"}, {"text": "Forward 5'-CGGGATCCAGCGGTTTGGTGAAAATGTC-3'", "cite_spans": [], "ref_spans": [], "section": "Sequence"}, {"text": "Reverse 5'-CCGCTCGAGCTGCATAACCACACCCATAAT -3'", "cite_spans": [], "ref_spans": [], "section": "3CL Pro"}, {"text": "Reverse 5'-CCGCTCGAGTTGGAAGGTAACACCAGAGC-3' ", "cite_spans": [], "ref_spans": [], "section": "3CL Pro"}, {"text": "To a solution of 3a (10 g, 30.45 mmol) dissolved into anhydrous MeOH (400 mL), ", "cite_spans": [], "ref_spans": [], "section": "Procedure for the preparation of methyl (S)-2-((tert-butoxycarbonyl)amino)-3-((S)-2-oxopiperidin-3-yl)propanoate 4a"}, {"text": "The similar procedure with the procedure to generate compound 4a was executed to synthesize compound 4b. 1 ", "cite_spans": [{"start": 105, "end": 106, "text": "1", "ref_id": "BIBREF1"}], "ref_spans": [], "section": "Procedure for the preparation of methyl (S)-2-((tert-butoxycarbonyl)amino)-3-((S)-2-oxopyrrolidin-3-yl)propanoate 4b"}, {"text": "To a solution of 4a (1.0 g, 3.33 mmol) dissolved in anhydrous DCM (50 mL), (M+H) + .", "cite_spans": [], "ref_spans": [], "section": "5a."}, {"text": "The detailed equivalent and procedure of condensation reaction was referred to the procedure for the preparation of compound 5a. 1 ", "cite_spans": [{"start": 129, "end": 130, "text": "1", "ref_id": "BIBREF1"}], "ref_spans": [], "section": "Procedure for the preparation of Methyl (S)-2-((S)-2-cinnamamido-4methylpentanamido)-3-((S)-2-oxopiperidin-3-yl)propanoate 6a"}, {"text": "To Figure S28 . The forming process to generate hemiacetals from aldehyde.", "cite_spans": [], "ref_spans": [{"start": 3, "end": 13, "text": "Figure S28", "ref_id": "FIGREF22"}], "section": "Procedure for the preparation of compounds 8a-b."}, {"text": "Hz The detailed equivalent and procedure of reduction reaction was referred to the procedure for the preparation of 7a.", "cite_spans": [], "ref_spans": [], "section": "(S)-2-cinnamamido-4-methyl-N-((S)-1-oxo-3-((S)-2-oxopyrrolidin-3yl)propan-2-yl)pentanamide 8b"}, {"text": "11a. ", "cite_spans": [], "ref_spans": [], "section": "N-((S)-1-(((S)-1-(((S)-1-hydroxy-3-((S)-2-oxopiperidin-3-yl)propan-2yl)amino)-4-methyl-1-oxopentan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)benzamide"}, {"text": "yl)isonicotinamide 11b. 1 The detailed equivalent and procedure of reduction reaction was referred to the procedure for the preparation of 8a. ", "cite_spans": [{"start": 24, "end": 25, "text": "1", "ref_id": "BIBREF1"}], "ref_spans": [], "section": "N-((S)-1-(((S)-1-(((S)-1-hydroxy-3-((S)-2-oxopiperidin-3-yl)propan-2yl)amino)-4-methyl-1-oxopentan-2-yl)amino)-3-methyl-1-oxobutan-2-"}], "bib_entries": {"BIBREF0": {"ref_id": "b0", "title": "= 5.2 Hz, 6H), 0.89 (dd, J = 10.2, 5.5 Hz, 6H). 13 C NMR (101 MHz", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF1": {"ref_id": "b1", "title": "Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features", "authors": [{"first": "W", "middle": [], "last": "Kabsch", "suffix": ""}, {"first": "C", "middle": [], "last": "Sander", "suffix": ""}], "year": 1983, "venue": "Biopolymers", "volume": "22", "issn": "", "pages": "2577--2637", "other_ids": {}}, "BIBREF2": {"ref_id": "b2", "title": "Knowledge-Based Protein Secondary Structure Assignment", "authors": [{"first": "D", "middle": [], "last": "Frishman", "suffix": ""}, {"first": "P", "middle": [], "last": "Argos", "suffix": ""}], "year": 1995, "venue": "Proteins: Struct., Funct., Genet", "volume": "23", "issn": "", "pages": "566--579", "other_ids": {}}, "BIBREF3": {"ref_id": "b3", "title": "DDOMAIN: Dividing structures into domains using a normalized domain-domain interaction profile", "authors": [{"first": "H", "middle": [], "last": "Zhou", "suffix": ""}, {"first": "B", "middle": [], "last": "Xue", "suffix": ""}, {"first": "Y", "middle": [], "last": "Zhou", "suffix": ""}], "year": 2007, "venue": "Protein Sci", "volume": "16", "issn": "", "pages": "947--955", "other_ids": {}}, "BIBREF4": {"ref_id": "b4", "title": "The CATH Domain Structure Database and related resources Gene3D and DHS provide comprehensive domain family information for genome analysis", "authors": [{"first": "F", "middle": [], "last": "Pearl", "suffix": ""}, {"first": "A", "middle": [], "last": "Todd", "suffix": ""}, {"first": "I", "middle": [], "last": "Sillitoe", "suffix": ""}, {"first": "M", "middle": [], "last": "Dibley", "suffix": ""}, {"first": "O", "middle": [], "last": "Redfern", "suffix": ""}, {"first": "T", "middle": [], "last": "Lewis", "suffix": ""}, {"first": "C", "middle": [], "last": "Bennett", "suffix": ""}, {"first": "R", "middle": [], "last": "Marsden", "suffix": ""}, {"first": "A", "middle": [], "last": "Grant", "suffix": ""}, {"first": "D", "middle": [], "last": "Lee", "suffix": ""}, {"first": "A", "middle": [], "last": "Akpor", "suffix": ""}, {"first": "M", "middle": [], "last": "Maibaum", "suffix": ""}, {"first": "A", "middle": [], "last": "Harrison", "suffix": ""}, {"first": "T", "middle": [], "last": "Dallman", "suffix": ""}, {"first": "G", "middle": [], "last": "Reeves", "suffix": ""}, {"first": "I", "middle": [], "last": "Diboun", "suffix": ""}, {"first": "S", "middle": [], "last": "Addou", "suffix": ""}, {"first": "S", "middle": [], "last": "Lise", "suffix": ""}, {"first": "C", "middle": [], "last": "Johnston", "suffix": ""}, {"first": "A", "middle": [], "last": "Sillero", "suffix": ""}, {"first": "J", "middle": [], "last": "Thornton", "suffix": ""}, {"first": "C", "middle": [], "last": "Orengo", "suffix": ""}], "year": 2005, "venue": "Nucleic Acids Res", "volume": "33", "issn": "", "pages": "247--251", "other_ids": {}}}, "ref_entries": {"FIGREF0": {"text": "Bioinformatics analysis on the native substrate active sites of MERS-CoV 3CL Pro (left) and SARS-CoV 3CL Pro (right). Reported protease favoring residues of substrate are emphasized by color background.", "latex": null, "type": "figure"}, "FIGREF1": {"text": "Substrate cleavage capability of MERS-CoV 3CL Pro (left) and SARS-CoV 3CL Pro (right) in dose dependent and time dependent manner.", "latex": null, "type": "figure"}, "FIGREF2": {"text": "MD simulation calculation on the barycenter distance between 169th site residue side-chain terminal and 175th site residue side-chain terminal. (A) The time evolution of the distance in WT and mutation E169L. (B) The time evolution of the distance in WT and mutation H175L. (C) The time evolution of the distance in WT and mutation E169L H175L. (D) The distribution of the distance of (A). (E) The distribution of the distance of (B). (F) The distribution of the distance of (C).", "latex": null, "type": "figure"}, "FIGREF3": {"text": "MD simulation calculation on the wild type MERS-CoV 3CL Pro (in red) and mutation Y164F (in blue). (A) The time evolution of distance between H166 and substrate glutamine in WT (red) and mutation Y164F (blue). (B) The time evolution of dihedral of H166 (CD2-CG-CB-H) in WT (red) and mutation Y164F (blue).", "latex": null, "type": "figure"}, "FIGREF4": {"text": "MD simulation calculation on the WT MERS-CoV 3CL Pro (red) and mutation F143A (violet). (A) The time evolution of distance between H166 and substrate glutamine in WT (red) and mutation F143A (violet). (B) The time evolution of distance between H166 and Y164 in WT (red) and mutation F143A (violet). (C) The time evolution of dihedral of H166 (CD2-CG-CB-H) in WT (red) and mutation F143A (violet).", "latex": null, "type": "figure"}, "FIGREF5": {"text": "MD simulation calculation on the WT MERS-CoV 3CL Pro (red) and mutation F143L (cyan). (A) The time evolution of distance between H166 and substrate glutamine in WT (red) and mutation F143L (cyan). (B) The time evolution of distance between H166 and Y164 in WT (red) and mutation F143L (cyan). (C) The time evolution of dihedral of H166 (CD2-CG-CB-H) in WT (red) and mutation F143L (cyan).", "latex": null, "type": "figure"}, "FIGREF6": {"text": "Activity evaluation of related representative mutations in SARS-CoV 3CL Pro . The data presented are mean values from experiments in triplicate and the error bars indicate standard deviations.", "latex": null, "type": "figure"}, "FIGREF7": {"text": "Superimposition of SARS-CoV 3CL Pro (green) with HCoV-229E 3CL Pro (purple) (A) and HCoV-NL63 3CL Pro (gray) (B). Owing to holding similar surrounding of the S144 in SARS-CoV 3CL Pro with A143 in HCoV-229E 3CL Pro and HCoV-NL63 3CL Pro , SARS-CoV 3CL Pro was utilized to verify the significant roles of S144.", "latex": null, "type": "figure"}, "FIGREF8": {"text": "MD simulation calculation on the wild type MERS-CoV 3CL Pro (red), mutation G146A (blue). (A) The time evolution of distance between 146 site residue and substrate glutamine. (B) The time evolution of angle between 146 site residue and substrate glutamine (N-H-O). (C) The distribution of the distance of (A). (D) The distribution of the angle of (B).", "latex": null, "type": "figure"}, "FIGREF9": {"text": "The average structure of the WT and mutants extracted from last 10 ns trajectory following MD simulation.", "latex": null, "type": "figure"}, "FIGREF10": {"text": "PMF calculation for the SG atom of C148 -substrate glutamine carbonyl group distance vs the RMSD of total system in WT MERS-CoV 3CL Pro (left), G149A mutant (center), and G149P mutant (right).", "latex": null, "type": "figure"}, "FIGREF11": {"text": "The average structure of attacking state (A) and resting-state (B) of MERS-CoV 3CL Pro to manifest the detail features of the two-state.", "latex": null, "type": "figure"}, "FIGREF12": {"text": "Superimposition of two typical conformation (attacking state and resting state) of MERS-CoV 3CL Pro in MD simulation.", "latex": null, "type": "figure"}, "FIGREF13": {"text": "MD simulation calculation on the wild type MERS-CoV 3CL Pro . (A) The time evolution of \u03c6 dihedral of C148. (B) The time evolution of \u03c8 dihedral of C148.", "latex": null, "type": "figure"}, "FIGREF14": {"text": "MD simulation calculation on the WT MERS-CoV 3CL Pro (red), mutation G149P (purple). (A) The time evolution of distance between C148 and H166, which indicated C148 formed compact connection to H166 in mutation G149P. (B) The time evolution of angle between C148 and H166 (S-H-O), which indicated stable the hydrogen interaction between C148 and H166. (C) The distribution of the distance in (A). (D) The distribution of the angle in (B).", "latex": null, "type": "figure"}, "FIGREF15": {"text": "Conserved analysis on the sequence of six common coronavirus 3CL Pro .The significant residues of MERS-CoV 3CL Pro and SARS-CoV 3CL Pro are highlighted.", "latex": null, "type": "figure"}, "FIGREF16": {"text": "Enzymatic activity analysis on related representative mutations in SARS-CoV 3CL Pro . The data presented are mean values from experiments in triplicate and the error bars indicate standard deviations.", "latex": null, "type": "figure"}, "FIGREF17": {"text": "MD simulation calculation on the WT MERS-CoV 3CL Pro (red), mutation S178A (blue) and mutation T88A (violet). (A) The time evolution of RMSD of Q167. (B) The time evolution of RMSD of Q167.", "latex": null, "type": "figure"}, "FIGREF18": {"text": "The time evolution of RMSD of Q167 in multipoints mutant T88C/S178T (cyan).", "latex": null, "type": "figure"}, "FIGREF19": {"text": "MD simulation calculation on the wild type MERS-CoV 3CL Pro (red), mutation M168L (blue). (A) The time evolution of the distance between D190 and protonated histidine. (B) The relative distribution of the distance in (A).", "latex": null, "type": "figure"}, "FIGREF20": {"text": "Kinetic parameters of the WT and mutation M165L of SARS-CoV 3CL Pro .", "latex": null, "type": "figure"}, "FIGREF21": {"text": "MD simulation calculation on the WT MERS-CoV 3CL Pro binding to the compound 12b. (A) The time evolution of the distance between Q195 and N atom of the pyridine ring. (B) The time evolution of the angle originated from N (main chain N atom in Q195)-H (main amide bond H atom in Q195)-N (N atom in the pyridine ring of the compound 12b).", "latex": null, "type": "figure"}, "FIGREF22": {"text": "anhydrous THF; 99% for two steps. (b) (1) LiHMDS, argon atmosphere, anhydrous THF; -78 o C; (2) BrCH 2 CN or BrCH 2 CH 2 CN, argon atmosphere, anhydrous THF, 3 h, -78 o C. 62% for two steps. (c) CoCl 2 \u00b76H 2 O, NaBH 4 , MeOH, 0 o C, 2 days, 39.5%. (d) (1) TFA, DCM, RT, 3 h; (2) adjust pH value to 7, (S)-Boc-Leu-OH , EDCI, HOBt and TEA, DCM; 60.4% for two steps; (e) (1) TFA, DCM, RT, 3h; (2) adjust pH value to 7, cinnamic acid, EDCI, HOBt and TEA, DCM; 61% for two steps; Reagents and conditions: (a) (1) TFA, DCM, RT, 3 h; (2) adjust pH value to 7, (S)-Boc-Val-OH , EDCI, HOBt and TEA, DCM; 54% for two steps; (b) (1) TFA, DCM, RT, 3 h; (2) adjust pH value to 7, benzoic acid or isonicotinic acid, EDCI, HOBt and TEA, DCM; 52% for two steps; (c) NaBH 4 , MeOH, RT, 2 h, 71%; (g) Dess-Martin periodinane, DCM, RT, 1 h, 83%.", "latex": null, "type": "figure"}, "FIGREF23": {"text": "H NMR (400MHz, CDCl 3 ) \u03b4: 8.46 (d, J = 6.8 Hz, 1H), 7.58 (d, J = 15.6 Hz, 1H), 7.51 -7.43 (m, 2H), 7.39 -7.30 (m, 3H), 7.19 (s, 1H), 7.10 (d, J = 8.8 Hz, 1H), 6.53 (d, J = 15.6 Hz, 1H), 5.01 (td, J = 8.1.57 (m, 2H), 1.53 -1.39 (m, 1H), 0.97 (d, J = 3.7 Hz, 6H", "latex": null, "type": "figure"}, "FIGREF24": {"text": "Procedure for the preparation of compounds 7a-b. To a solution of 6a-b (0.90 mmol) dissolved into anhydrous MeOH (30.0 mL), NaBH 4 (0.51 g, 13.53 mmol) was added at 0 \u00b0C. Then, the reaction mixture was stirred at ambient temperature for 2 h. Saturated NH 4 Cl solution (20 mL) was added to the mixture for quench the reaction. Following evaporating the solvent, EA (60 mL\u00d72) was added to extract the aqueous components. The organic phase was washed with H 2 O (30 mL\u00d72), saturated brine (30 mL\u00d72), and concentrated. Finally, the residue was purified by column chromatography (DCM: MeOH, 25:1 v/v) to afford the pure product as a white solid 7a-b (yield 79% -81%).", "latex": null, "type": "figure"}, "FIGREF25": {"text": "a solution of 7a-b (0.48 mmol) in anhydrous DCM (30.0 mL), Dess-Martin reagent (306.2 mg, 0.72 mmol) was added at ice-bath. Then, the reaction mixture was allowed to stir at ambient temperature for 2 h. A solution of NaHCO 3 and solid Na 2 S 2 O 3 were added to quench the reaction. After 40 min of string, the reaction mixture was extracted by DCM (30.0 mL \u00d7 2). The organic phase was washed with brine (30 mL \u00d7 2), dried over Na 2 SO 4 , and concentrated, and the residue was purified by column chromatography (DCM: MeOH, 50:1 to 35:1 v/v) to afford the pure product as a white solid 8a-b (yield 86%-91%). Owing the existence of MeOH, the aldehyde prefer to form diastereoisomers hemiacetals (Figure S28). For obtaining the purity aldehyde as far as possible, abundant CCl 4 and hexane were added into the eluent to form azeotropes.Then, the eluent was concentrated at 44 o C and give the residue which mainly contain aldehyde. Following the abundant hexane was added into the solution of residue dissolved into chloroform, the precipitation was filtered and give the purity aldehyde.", "latex": null, "type": "figure"}, "FIGREF26": {"text": "The NMR figures of compound 8a. The NMR figures of compound 8b. The NMR figures of compound 12a. The NMR figures of compound 12b. S3. The model for the reaction system. During the geometry optimization, the boundary atoms are fixed at the position as they were in the protein environment. 42 Supporting figures in MD simulation Figure S33. The time evolution of RMSD of WT MERS-CoV 3CL Pro in MD simulation.", "latex": null, "type": "figure"}, "FIGREF27": {"text": "The time evolution of RMSD of mutant E169L in MD simulation.", "latex": null, "type": "figure"}, "FIGREF28": {"text": "The time evolution of RMSD of mutant H175L in MD simulation.", "latex": null, "type": "figure"}, "FIGREF29": {"text": "The time evolution of RMSD of mutant E169L/H175L in MD simulation.", "latex": null, "type": "figure"}, "FIGREF30": {"text": "The time evolution of RMSD of mutant Y164F in MD simulation.", "latex": null, "type": "figure"}, "FIGREF31": {"text": "The time evolution of RMSD of mutant F143L in MD simulation.", "latex": null, "type": "figure"}, "FIGREF32": {"text": "The time evolution of RMSD of mutant F143A in MD simulation.", "latex": null, "type": "figure"}, "FIGREF33": {"text": "The time evolution of RMSD of mutant G146A in MD simulation. The time evolution of RMSD of mutant G146P in MD simulation.", "latex": null, "type": "figure"}, "FIGREF34": {"text": "The time evolution of RMSD of mutant S147A in MD simulation.", "latex": null, "type": "figure"}, "FIGREF35": {"text": "The time evolution of RMSD of mutant G149A in MD simulation.", "latex": null, "type": "figure"}, "FIGREF36": {"text": "The time evolution of RMSD of mutant G149P in MD simulation.", "latex": null, "type": "figure"}, "FIGREF37": {"text": "The time evolution of RMSD of mutant S150A in MD simulation.", "latex": null, "type": "figure"}, "FIGREF38": {"text": "The time evolution of RMSD of mutant N28L in MD simulation: The time evolution of RMSD of wild types which was extracted water in MD simulation.", "latex": null, "type": "figure"}, "FIGREF39": {"text": "The time evolution of RMSD of mutant Q167A in MD simulation.", "latex": null, "type": "figure"}, "FIGREF40": {"text": "The time evolution of RMSD of mutant Q167V in MD simulation.", "latex": null, "type": "figure"}, "FIGREF41": {"text": "The time evolution of RMSD of mutant Q167L in MD simulation.", "latex": null, "type": "figure"}, "FIGREF42": {"text": "The time evolution of RMSD of mutant M168L in MD simulation.", "latex": null, "type": "figure"}, "FIGREF43": {"text": "The time evolution of RMSD of mutant T88A in MD simulation.", "latex": null, "type": "figure"}, "FIGREF44": {"text": "The time evolution of RMSD of mutant S178A in MD simulation.", "latex": null, "type": "figure"}, "FIGREF45": {"text": "The time evolution of RMSD of mutant T88C/S178T in MD simulation.", "latex": null, "type": "figure"}, "FIGREF46": {"text": "The time evolution of RMSD of MERS-CoV 3CL Pro which binds to 12a in MD simulation.", "latex": null, "type": "figure"}, "FIGREF47": {"text": "The time evolution of RMSD of MERS-CoV 3CL Pro which binds to 12b in MD simulation.", "latex": null, "type": "figure"}, "FIGREF48": {"text": "The time evolution of RMSD of wild type which was preconditioned before QM in MD simulation (first step of cleavage process).", "latex": null, "type": "figure"}, "TABREF1": {"text": "The designed primers for proteion mutagenesis.", "latex": null, "type": "table", "html": "<html><body><table><tr><td>Species </td><td>Mutation </td><td>\u00a0</td><td>Sequence (5'-3')\n</td></tr><tr><td>MERS-\n</td><td>C148A </td><td>Forward </td><td>TTTCTGTGTGGTTCTGCTGGTAGTGTTG</td></tr><tr><td>CoV\n</td><td>\u00a0</td><td>Reverse </td><td>GCAGAACCACACAGAAAGGAACCCTTA\n</td></tr><tr><td>C148S </td><td>Forward </td><td>TCCTTTCTGTGTGGTTCTTCTGGTAGTGTTG</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>Reverse </td><td>GAAGAACCACACAGAAAGGAACCCTTAATTG\n</td></tr><tr><td>\u00a0</td><td>C145A </td><td>Forward </td><td>ATTAAGGGTTCCTTTCTGGCTGGTTCTTGTGG</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>Reverse </td><td>GCCAGAAAGGAACCCTTAATTGTGTAGTTAGGGCG\n</td></tr><tr><td>\u00a0</td><td>C145S </td><td>Forward </td><td>ATTAAGGGTTCCTTTCTGTCTGGTTCTTGTG</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>Reverse </td><td>GACAGAAAGGAACCCTTAATTGTGTAGTTAGG\n</td></tr><tr><td>\u00a0</td><td>H41A </td><td>Forward </td><td>ACAGTCTGGTGCCCACGAGCCGTAATGTGCC</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>Reverse </td><td>GCTCGTGGGCACCAGACTGTGTTGTCAAGCC\n</td></tr><tr><td>\u00a0</td><td>H41L </td><td>Forward </td><td>GTCTGGTGCCCACGACTTGTAATGTGCCC</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>Reverse </td><td>AAGTCGTGGGCACCAGACTGTGTTGTCAAGC\n</td></tr><tr><td>\u00a0</td><td>H166A </td><td>Forward </td><td>CAATTTCTGTTACATGGCTCAAATGGAAC</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>Reverse </td><td>GCCATGTAACAGAAATTGATCACACTACC\n</td></tr><tr><td>\u00a0</td><td>H166L </td><td>Forward </td><td>ATCAATTTCTGTTACATGCTTCAAATGGAAC</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>Reverse </td><td>AGCATGTAACAGAAATTGATCACACTACCC\n</td></tr><tr><td>\u00a0</td><td>H166Q </td><td>Forward </td><td>AATTTCTGTTACATGCAGCAAATGGAAC</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>Reverse </td><td>CTGCATGTAACAGAAATTGATCACACTACCC\n</td></tr><tr><td>\u00a0</td><td>H166N </td><td>Forward </td><td>ATCAATTTCTGTTACATGAATCAAATGGAAC</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>Reverse </td><td>TCATGTAACAGAAATTGATCACACTACCCTC\n</td></tr><tr><td>\u00a0</td><td>Y164A </td><td>Forward </td><td>AGTGTGATCAATTTCTGTGCCATGCATCAAATG</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>Reverse </td><td>GCACAGAAATTGATCACACTACCCTCCTTG\n</td></tr><tr><td>\u00a0</td><td>Y164F </td><td>Forward </td><td>GTGTGATCAATTTCTGTTTCATGCATCAAATGG</td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>Reverse </td><td>AAACAGAAATTGATCACACTACCCTCCTTG\n</td></tr><tr><td>\u00a0</td><td>Y164R </td><td>Forward </td><td>GTGTGATCAATTTCTGTCGCATGCATCAAATGG\n</td></tr></table></body></html>"}, "TABREF10": {"text": "1H), 2.19 -1.98 (m, 3H), 1.97 -1.83 (m, 1H), 1.79 -1.56 (m, 5H), 1.51 -1.37 (m, 1H), 0.97 (d, J = 6.4 Hz, 6H), 0.91 (dd, J = 16.1, 6.1 Hz, 6H). 13 C NMR (101 MHz, CDCl 3 ) \u03b4: 175.47, 173.39, 172.14, 171.99, 165.42, 148.14, 142.66, 121.03, 20.35, 19.31, 18.91. ESI-MS (m/z):540.8 (M+Na) + . 2.1.10. Procedure for the preparation of compounds 11a-11b.", "latex": null, "type": "table"}, "TABREF11": {"text": "30.67, 25.72, 24.47, 21.97, 20.79, 20.75, 18.56, 17.94. ESI-MS (m/z):511.4 (M+ Na) + .", "latex": null, "type": "table"}, "TABREF12": {"text": "Procedure for the preparation of compounds 12a-12b.", "latex": null, "type": "table"}}, "back_matter": []}